The evidence convincingly shows that aducanumab (Aduhelm) removes beta amyloid — a hallmark of Alzheimer’s — from the brain, slowing the disease’s progression and giving patients and families much-needed hope, FDA says. But long-term care clinicians are not keen on the drug, with some saying they will not prescribe it.
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Researchers were able to predict mild cognitive impairment and dementia with 88% accuracy when analyzing results from in-vehicle recording devices in a real-world setting.
A primary care toolkit for brain health assessment and dementia diagnosis has gotten a much-needed update as more research points to the potential for better outcomes with earlier diagnoses, the authors and reviewers say.
People with cognitive impairment who have sleep apnea are more likely to score lower on tests of cognitive function than their peers without sleep apnea. And the more severe the apnea, the greater the degree of cognitive decline, a new study finds.
High blood pressure is tied to lower global cognitive and memory test scores, a long-term study shows.
Missed bill payments and lowered credit scores may be evident years before a dementia diagnosis, a new study shows. Earlier diagnosis could help protect patients’ financial well-being, investigators say.
Study participants who began a weekly exercise routine after diagnosis with MCI had an 11% lower risk of progressing to Alzheimer’s when compared with people who did not exercise at all, a new study finds. Those who stopped exercising appeared to lose that advantage.
Researchers have found new potential for a safe and widely used medication. The discovery could be “life-changing” for patients at risk of dementia, they say.
Spousal loss is a highly stressful life event that may have deleterious effects on the brain, a new study finds.
